Active Engineering
HT3 Phase 3
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by UKRI.
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
HT3 Phase 2
Phase 3, randomized, double blind, placebo vs pf-06939926 study in dmd
A Phase 3, Randomized, Double-blind, Placebo controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients- HYPERION
Phase I/IIa Study of DTP3 in Patients With Advanced MM and DLBCL
A Phase IIB, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants with a Prior Myocardial Infarction, Persistent Inflammation, and Elevated N-terminal Prohormone Brain Natriuretic Peptide
Original classification
Legacy Department of Trade & IndustryPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know